Zobrazeno 1 - 10
of 53
pro vyhledávání: '"David P Schladt"'
Autor:
Rui Cao, David P Schladt, Casey Dorr, Arthur J Matas, William S Oetting, Pamala A Jacobson, Ajay Israni, Jinbo Chen, Weihua Guan
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0303446 (2024)
BackgroundAcute rejection (AR) after kidney transplantation is an important allograft complication. To reduce the risk of post-transplant AR, determination of kidney transplant donor-recipient mismatching focuses on blood type and human leukocyte ant
Externí odkaz:
https://doaj.org/article/999668b711c345a1a76402758a81e39e
Autor:
Casey Dorr, Baolin Wu, Weihua Guan, Amutha Muthusamy, Kinjal Sanghavi, David P Schladt, Jonathan S Maltzman, Steven E Scherer, Marcia J Brott, Arthur J Matas, Pamala A Jacobson, William S Oetting, Ajay K Israni
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0125045 (2015)
We performed RNA sequencing (RNAseq) on peripheral blood mononuclear cells (PBMCs) to identify differentially expressed gene transcripts (DEGs) after kidney transplantation and after the start of immunosuppressive drugs. RNAseq is superior to microar
Externí odkaz:
https://doaj.org/article/e36481d1a5dc4a60b1328e47bbb647b2
Autor:
Maryam Valapour, Carli J. Lehr, David P. Schladt, Jodi M. Smith, Rebecca Goff, Tatenda G. Mupfudze, Kaitlin Swanner, Katrina Gauntt, Jon J. Snyder
Publikováno v:
American Journal of Transplantation. 23:S379-S442
Autor:
David P. Schladt, Ajay K. Israni
Publikováno v:
American Journal of Transplantation. 23:S12-S20
Publikováno v:
American Journal of Transplantation. 21:222-228
The current pediatric end-stage liver disease (PELD) score underestimates pediatric waitlist mortality. Children frequently require PELD exception points to achieve appropriate priority ranking. We developed a new PELD score using serum sodium, creat
Autor:
David P. Schladt, Ajay K. Israni, Robbin Itzler, David Zaun, Bertram L. Kasiske, Allyson Hart
Publikováno v:
Journal of Medical Economics. 24:1011-1017
Antibody-mediated rejection (AMR) is one of the leading causes of graft loss in kidney transplant recipients but little is known about the associated cost and healthcare burden of AMR.We developed an algorithm to detect AMR using the 2006-2011 Center
Autor:
Gen Investigators, Ajay K. Israni, Arthur J. Matas, Baolin Wu, David P. Schladt, Casey R. Dorr, Rory P. Remmel, DeKAF Genomics, Pamala A. Jacobson, David Ikle, William S. Oetting, Roslyn B. Mannon, Weihua Guan
Publikováno v:
Transplantation. 103:1591-1602
Background Identifying kidney allograft recipients who are predisposed to acute rejection (AR) could allow for optimization of clinical treatment to avoid rejection and prolong graft survival. It has been hypothesized that a part of this predispositi
Autor:
Allyson Hart, Ajay K. Israni, Bertram L. Kasiske, Arthur J. Matas, David P. Schladt, Robbin Itzler
Publikováno v:
Clinical Transplantation. 35
Major gaps remain in our understanding of antibody-mediated rejection (AMR) after kidney transplant. We examined the incidence, risk factors, response to treatment, and effects on outcomes of AMR at seven transplant programs in the long-term Deterior
Autor:
W. R. Kim, Jon J. Snyder, J. Foutz, M. Cafarella, Bertram L. Kasiske, Jodi M. Smith, S E Booker, S. M. Noreen, Allison J. Kwong, Ajay K. Israni, M. A. Skeans, John R. Lake, David P. Schladt
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 21
This year was notable for changes to exception points determined by the geographic median allocation Model for End-Stage Liver Disease (MELD) and implementation of the National Liver Review Board, which took place on May 14, 2019. The national acuity
Autor:
Sauman Chu, Cory R. Schaffhausen, Ajay K. Israni, Warren T McKinney, Tamas Alexy, Jon J. Snyder, Bertram L. Kasiske, David P. Schladt, Marylin J. Bruin, Cindy M. Martin
Publikováno v:
Clin Transplant
BACKGROUND: The Scientific Registry of Transplant Recipients provides transplant program-specific information, but it is unclear what patients and stakeholders need to know. Acceptance criteria for the candidate waitlist and donor organs vary by prog